These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2659855)

  • 1. Electrophoretic studies of muscle proteins in Duchenne muscular dystrophy and other neuromuscular disorders--with special reference to the change of dystrophin.
    Uchino M; Araki S; Miike T
    Jpn J Med; 1989; 28(2):170-4. PubMed ID: 2659855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization and characterization of dystrophin in muscle biopsy specimens from Duchenne muscular dystrophy and various neuromuscular disorders.
    Uchino M; Araki S; Miike T; Teramoto H; Nakamura T; Yasutake T
    Muscle Nerve; 1989 Dec; 12(12):1009-16. PubMed ID: 2695839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical study of connectin (titin) in neuromuscular diseases using a monoclonal antibody: connectin is degraded extensively in Duchenne muscular dystrophy.
    Matsumura K; Shimizu T; Nonaka I; Mannen T
    J Neurol Sci; 1989 Nov; 93(2-3):147-56. PubMed ID: 2592979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dystrophin and nebulin in the muscular dystrophies.
    Patel K; Voit T; Dunn MJ; Strong PN; Dubowitz V
    J Neurol Sci; 1988 Nov; 87(2-3):315-26. PubMed ID: 3062133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface.
    Bonilla E; Samitt CE; Miranda AF; Hays AP; Salviati G; DiMauro S; Kunkel LM; Hoffman EP; Rowland LP
    Cell; 1988 Aug; 54(4):447-52. PubMed ID: 3042151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy.
    Nicholson LV; Johnson MA; Gardner-Medwin D; Bhattacharya S; Harris JB
    Acta Neuropathol; 1990; 80(3):239-50. PubMed ID: 2205076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
    Wang X; Xie Y; Zhang C; Liu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of myosin isoforms and of desmin, vimentin and titin in Tunisian Duchenne-like autosomal recessive muscular dystrophy.
    Hamida CB; Soussi-Yanicostas N; Bejaoui K; Butler-Browne GS; Hentati F; Ben Hamida M
    J Neurol Sci; 1994 May; 123(1-2):114-21. PubMed ID: 8064303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophin: the protein product of the Duchenne muscular dystrophy locus.
    Hoffman EP; Brown RH; Kunkel LM
    Cell; 1987 Dec; 51(6):919-28. PubMed ID: 3319190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy.
    Nicholson LV; Davison K; Johnson MA; Slater CR; Young C; Bhattacharya S; Gardner-Medwin D; Harris JB
    J Neurol Sci; 1989 Dec; 94(1-3):137-46. PubMed ID: 2693618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of dystrophin test for patients with various neuromuscular diseases--immunofluorescence and immunoblot analyses of dystrophin abnormalities].
    Ikeya K; Saito K; Yamauchi A; Kondo E; Komine S; Ikenaka H; Mishima M; Takahashi R; Harada T; Fukuyama Y
    No To Hattatsu; 1993 Jul; 25(4):328-34. PubMed ID: 8338694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered alpha1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies.
    Wakayama Y; Inoue M; Kojima H; Jimi T; Yamashita S; Kumagai T; Shibuya S; Hara H; Oniki H
    Histol Histopathol; 2006 Jan; 21(1):23-34. PubMed ID: 16267784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystrophin immunostaining of muscle from Chinese patients with various neuromuscular diseases.
    Jong YJ; Chuang YH; Chen SS; Chen BH; Chiang CH
    J Formos Med Assoc; 1991 Dec; 90(12):1143-8. PubMed ID: 1686882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma.
    Ohlendieck K; Matsumura K; Ionasescu VV; Towbin JA; Bosch EP; Weinstein SL; Sernett SW; Campbell KP
    Neurology; 1993 Apr; 43(4):795-800. PubMed ID: 8469343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mosaic pattern of dystrophins in Duchenne muscular dystrophy.
    Tachi N; Sasaki K; Yamada T; Imamura S; Mike T
    Pediatr Neurol; 1990; 6(1):54-6. PubMed ID: 2178618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of dystrophin in muscular diseases by two-dimensional gel electrophoresis using agarose gels in the first dimension.
    Hamano K; Takeya T; Iwasaki N; Okoshi N; Fukubayashi T; Kirinoki M; Yao Y; Hirabayashi T; Takita H
    Acta Neurol Belg; 1996 Jun; 96(2):102-7. PubMed ID: 8711982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro skeletal muscle protein and RNA incorporation in neuromuscular disease.
    Tomkins JK; Collins SP; Baker WD; Kidman AD
    J Neurol Sci; 1982 Apr; 54(1):59-68. PubMed ID: 6176687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
    Mizuno Y; Nonaka I; Hirai S; Ozawa E
    J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the mysteries of Duchenne and Becker muscular dystrophy.
    Hyser CL
    Mol Chem Neuropathol; 1989 Feb; 10(1):15-20. PubMed ID: 2660836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Presence of dystrophine-like protein at the neuromuscular junction in Duchenne muscular dystrophy and in "mdx" mutant mice].
    Fardeau M; Tomé FM; Collin H; Augier N; Pons F; Léger J; Léger J
    C R Acad Sci III; 1990; 311(5):197-204. PubMed ID: 2119867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.